X0704 D LIVE 0001412067 Oncothyreon Inc. 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 (206) 801-2100 DELAWARE Biomira CORP Corporation true 2007 ROBERT L. KIRKMAN 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Executive Officer Director GARY CHRISTIANSON 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Executive Officer JULIA MARIE EASTLAND 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Executive Officer CHRISTOPHER S. HENNEY 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Director RICHARD L. JACKSON 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Director DANIEL K. SPIEGELMAN 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Director W. VICKERY STOUGHTON 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Director DOUGLAS WILLIAMS 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 Director Biotechnology $1,000,001 - $5,000,000 06 false 2010-09-28 false true true true false 0 JMP SECURITIES LLC 22208 None None 600 MONTGOMERY STREET SUITE 1100 SAN FRANCISCO CA CALIFORNIA 94111 CA CALIFORNIA IL ILLINOIS ME MAINE NE NEBRASKA NY NEW YORK false ROTH CAPITAL PARTNERS, LLC 15407 None None 24 CORPORATE PLAZA NEWPORT BEACH CA CALIFORNIA 92660 CA CALIFORNIA false 28342348 14850045 13492303 The Issuer sold an aggregate of 4,242,870 units to the investors at a price per unit of $3.50. Each unit consisted of one share of common stock and a warrant to purchase 0.75 of a share of common stock at an exercise price of $4.24 per share. false 17 891003 75000 The amounts shown above are the total amounts paid to both of the placement agents. 0 Proceeds are to be used for general corporate purposes. false Oncothyreon Inc. /s/ Robert L. Kirkman Robert L. Kirkman President and Chief Executive Officer 2010-10-06